Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BIOREFERENCE HEALTH, LLC

NPI: 1528331881 · GAITHERSBURG, MD 20877 · Clinical Medical Laboratory · NPI assigned 02/17/2012

$8K
Total Medicaid Paid
4,591
Total Claims
4,485
Beneficiaries
28
Codes Billed
2018-11
First Month
2024-10
Last Month

Provider Details

Authorized OfficialSCHMID, MICHAEL (SVP, CHIEF FINANCIAL OFFICER)
Parent OrganizationBIOREFERENCE HEALTH, LLC
NPI Enumeration Date02/17/2012

Related Entities

Other providers sharing the same authorized official: SCHMID, MICHAEL

ProviderCityStateTotal Paid
BIOREFERENCE HEALTH, LLC ELMWOOD PARK NJ $620.07M
BIOREFERENCE HEALTH, LLC HOUSTON TX $8.87M
FLORIDA CLINICAL LABORATORY, INC MELBOURNE FL $549K
BIOREFERENCE HEALTH, LLC MINEOLA NY $175K
BIOREFERENCE HEALTH, LLC HOUSTON TX $117K
BIOREFERENCE HEALTH, LLC BURBANK CA $25K
BIOREFERENCE HEALTH, LLC HACKENSACK NJ $22.86

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 17 $0.00
2019 16 $0.00
2020 874 $5K
2021 1,353 $2K
2022 816 $260.00
2023 818 $494.92
2024 697 $148.55

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 309 302 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 25 25 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1,129 1,115 $675.31
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 762 750 $368.90
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 780 753 $365.81
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 214 211 $318.80
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 109 107 $238.75
87536 67 66 $183.79
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 39 39 $162.33
85610 29 29 $108.64
87481 81 75 $79.54
87340 145 144 $46.64
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 32 29 $38.21
86706 137 136 $36.86
80053 Comprehensive metabolic panel 62 56 $33.38
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 31 30 $27.30
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 12 12 $26.39
85025 Blood count; complete (CBC), automated, and automated differential WBC count 31 25 $12.00
86140 77 63 $9.00
83010 40 40 $0.00
87522 Neg quan hep c or qual rna 36 36 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 135 133 $0.00
86704 80 80 $0.00
84460 40 40 $0.00
86708 68 68 $0.00
82247 40 40 $0.00
82977 40 40 $0.00
82172 41 41 $0.00